# EF1a promoter to drive expression in DRG in vivo?

**URL:** <https://forum.painresearcher.net/t/ef1a-promoter-to-drive-expression-in-drg-in-vivo/331>\
**Category:** Reagents and Equipment\
**Created:** [November 17, 2017, 7:05pm UTC](https://forum.painresearcher.net/t/ef1a-promoter-to-drive-expression-in-drg-in-vivo/331 "2017-11-17T19:05:56Z")\
**Posts on this page:** 1\
**Showing post:** 13

<div class="post-metadata">

**Author:** ![PatriciaT](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.painresearcher.net/patriciat/32/522_2.png) [@PatriciaT](https://forum.painresearcher.net/u/PatriciaT)\
**Post date:** [August 15, 2025, 3:37pm UTC](https://forum.painresearcher.net/t/ef1a-promoter-to-drive-expression-in-drg-in-vivo/331/13 "2025-08-15T15:37:17Z")

</div>

I was visiting the forum and recalled that I can now add something to this thread. I finally tried AAV-EF1a intrathecal injections and the infection wasn’t successful in my cre animals. I tried AAV9-EF1α-mCherry-FLEX-DTA (homemade, not great titer) and AAV9-EF1α-flex-taCasp3-TeVp (Addgene, good titer). In my hands I’ve only got consistent and substantial DRG infections via intrathecal route with CAG promoter. Just in case it helps someone!

---

_[View the full topic](https://forum.painresearcher.net/t/ef1a-promoter-to-drive-expression-in-drg-in-vivo/331)._
